# Is Ibrutinib-related Atrial Fibrillation Dose Dependent

> **NCT06224452** · — · UNKNOWN · sponsor: **University Hospital, Caen** · enrollment: 18000 (estimated)

## Conditions studied

- Hematological Malignancy
- Atrial Fibrillation

## Interventions

- **DRUG:** ibrutinib exposure

## Key facts

- **NCT ID:** NCT06224452
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-01
- **Primary completion:** 2024-05-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 18000 (ESTIMATED)
- **Last updated:** 2024-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06224452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06224452, "Is Ibrutinib-related Atrial Fibrillation Dose Dependent". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06224452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*